Maltin Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Hold |
3,032
| – | – | 0.17% | 89 |
|
|
2025
Q1 | $388K | Sell |
3,032
-13
| -0.4% | -$1.66K | 0.18% | 91 |
|
|
2024
Q4 | $403K | Buy |
3,045
+1
| +0% | +$132 | 0.2% | 90 |
|
|
2024
Q3 | $443K | Buy |
3,044
+4
| +0.1% | +$582 | 0.22% | 81 |
|
|
2024
Q2 | $417K | Sell |
3,040
-80
| -3% | -$11K | 0.22% | 81 |
|
|
2024
Q1 | $428K | Buy |
3,120
+2
| +0.1% | +$274 | 0.24% | 80 |
|
|
2023
Q4 | $424K | Buy |
3,118
+6
| +0.2% | +$815 | 0.27% | 75 |
|
|
2023
Q3 | $381K | Hold |
3,112
| – | – | 0.27% | 81 |
|
|
2023
Q2 | $395K | Hold |
3,112
| – | – | 0.28% | 76 |
|
|
2023
Q1 | $402K | Buy |
3,112
+2
| +0.1% | +$258 | 0.29% | 74 |
|
|
2022
Q4 | $408K | Sell |
3,110
-20
| -0.6% | -$2.63K | 0.3% | 73 |
|
|
2022
Q3 | $366K | Buy |
3,130
+11
| +0.4% | +$1.29K | 0.29% | 83 |
|
|
2022
Q2 | $367K | Buy |
3,119
+1
| +0% | +$118 | 0.27% | 90 |
|
|
2022
Q1 | $406K | Buy |
3,118
+5
| +0.2% | +$651 | 0.27% | 82 |
|
|
2021
Q4 | $475K | Sell |
3,113
-135
| -4% | -$20.6K | 0.29% | 78 |
|
|
2021
Q3 | $525K | Sell |
3,248
-147
| -4% | -$23.8K | 0.32% | 67 |
|
|
2021
Q2 | $556K | Hold |
3,395
| – | – | 0.34% | 66 |
|
|
2021
Q1 | $511K | Sell |
3,395
-38
| -1% | -$5.72K | 0.33% | 64 |
|
|
2020
Q4 | $520K | Buy |
3,433
+1
| +0% | +$151 | 0.36% | 60 |
|
|
2020
Q3 | $465K | Sell |
3,432
-184
| -5% | -$24.9K | 0.33% | 59 |
|
|
2020
Q2 | $494K | Sell |
3,616
-17
| -0.5% | -$2.32K | 0.37% | 56 |
|
|
2020
Q1 | $391K | Buy |
3,633
+1
| +0% | +$108 | 0.33% | 57 |
|
|
2019
Q4 | $438K | Buy |
+3,632
| New | +$438K | 0.28% | 49 |
|